Antimalarial dosing regimens and drug resistance.

Antimalarial dosing regimens and drug resistance.

The contribution of underdosing to antimalarial treatment failure has been underappreciated. Most recommended dosage regimens are based on studies in non-pregnant adult patients. Young children and pregnant women, who bear the heaviest malaria burden, have the highest treatment failure rates. This h...

Descripció completa

Dades bibliogràfiques
Autors principals:	Barnes, K, Watkins, WM, White, N
Format:	Journal article
Idioma:	English
Publicat:	2008

Ítems similars

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
per: Barnes, K, et al.
Publicat: (2005)

Antimalarial drug resistance
per: White, N
Publicat: (2004)

Antimalarial drug resistance.
per: White, N
Publicat: (2004)

Antimalarial pharmacokinetics and treatment regimens.
per: White, N
Publicat: (1992)

The threat of antimalarial drug resistance
per: Hanboonkunupakarn, B, et al.
Publicat: (2016)

Antimalarial drug resistance: the pace quickens.
per: White, N
Publicat: (1992)

World Antimalarial Resistance Network (WARN) IV: clinical pharmacology.
per: Barnes, K, et al.
Publicat: (2007)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
per: Price, R, et al.
Publicat: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
per: Price, R, et al.
Publicat: (2007)

Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN).
per: Lourens, C, et al.
Publicat: (2010)

Delaying antimalarial drug resistance with combination chemotherapy.
per: White, N
Publicat: (1999)

Preventing antimalarial drug resistance through combinations.
per: White, N
Publicat: (1998)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
per: Olliaro Piero, et al.
Publicat: (2007-09-01)

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
per: Stepniewska, K, et al.
Publicat: (2008)

Loading dose in antimalarial prophylaxis.
per: White, N
Publicat: (1985)

Cardiotoxicity of antimalarial drugs.
per: White, N
Publicat: (2007)

How antimalarial drug resistance affects post-treatment prophylaxis.
per: White, N
Publicat: (2008)

Pharmacology of absorption and distribution: optimal use of antimalarial drugs in the treatment of severe falciparum malaria in Kenya.
per: Watkins, WM, et al.
Publicat: (1994)

The assessment of antimalarial drug efficacy.
per: White, N
Publicat: (2002)

Clinical pharmacokinetics of antimalarial drugs.
per: White, N
Publicat: (1985)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
per: Shibeshi MA, et al.
Publicat: (2020-11-01)

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
per: White, N
Publicat: (2013)

Does antimalarial mass drug administration increase or decrease the risk of resistance?
per: White, N
Publicat: (2016)

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria.
per: White, N, et al.
Publicat: (1996)

Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy.
per: Watkins, WM, et al.
Publicat: (1993)

Simplified antimalarial therapeutic monitoring: using the day-7 drug level?
per: White, N, et al.
Publicat: (2008)

How antimalarial drug resistance affects post-treatment prophylaxis
per: White Nicholas J
Publicat: (2008-01-01)

The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
per: Achan, J, et al.
Publicat: (2013)

Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN).
per: Lourens, C, et al.
Publicat: (2014)

Antimalarial drug toxicity: a review.
per: Taylor, W, et al.
Publicat: (2004)

Mode of action and features of antimalarial drugs
per: Nosten, F, et al.
Publicat: (1999)

Mode of action and features of antimalarial drugs.
per: Nosten, F, et al.
Publicat: (1999)

The evolution of drug-resistant malaria: the role of drug elimination half-life.
per: Hastings, I, et al.
Publicat: (2002)

Antimalarial mass drug administration in large populations and the evolution of drug resistance
per: Nguyen, TD, et al.
Publicat: (2023)

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
per: White, N
Publicat: (1997)

Bibliometric analysis of antimalarial drug resistance
per: Jialu Zhang, et al.
Publicat: (2024-02-01)

The global challenge of antimalarial drug resistance
per: Ringwald Pascal, et al.
Publicat: (2012-10-01)

A database of antimalarial drug resistance
per: Ringwald Pascal, et al.
Publicat: (2006-06-01)

Antimalarial mass drug administration in large populations and the evolution of drug resistance.
per: Tran Dang Nguyen, et al.
Publicat: (2023-01-01)

The assessment of antimalarial drug efficacy in vivo
per: White, NJ
Publicat: (2022)